In this edition:
GoldiLox: pirtobrutinib + glofitamab in mantle cell lymphoma with prior BTKi exposure
Trial eligibility of real-world Australian R/R DLBCL patients
Romosozumab in multiple myeloma with skeletal events & prior bisphosphonates
Chemotherapy-free treatment in Ph-positive ALL
Treatment changes for adult Ph-negative ALL
Adverse impacts of measurable cyclophosphamide on day 0 of allo-SCT
EMBRACE: a multidisciplinary model of care for inherited bone marrow failure syndromes
Remote patient monitoring after CART-cell therapy
Cold-stored platelets in bleeding patients undergoing cardiothoracic surgery
Red cell transfusions in pregnant/post-partum women in Northern Territory
Risk factors for clonal haematopoiesis of indeterminate potential (CHIP)
COBRRA: bleeding risk with rivaroxaban vs. apixaban in acute venous thromboembolism
Please login below to download this issue (PDF)